Litcius/Paper detail

Interleukin 33-mediated inhibition of A-type K<sup>+</sup> channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice

Yiru Wang, Xinyi Wang, Renfei Qi, Ying Lü, Tao Yu, Dongsheng Jiang, Yufang Sun, Xinghong Jiang, Chun‐Feng Liu, Yuan Zhang, Jin Tao

2022Theranostics22 citationsDOIOpen Access PDF

Abstract

Background: has been implicated in nociceptive pain behaviors. However, the underlying molecular and cellular mechanisms remain unclear. Methods: Using electrophysiological recording, immunoblot analysis, immunofluorescence labeling, reverse transcription-PCR, siRNA-mediated knockdown approach and behavior tests, we determined the role of IL-33 in regulating sensory neuronal excitability and pain sensitivity mediated by A-type K + channels. Results: IL-33 decreased A-type transient outward K + currents (IA) in small-sized DRG neurons in a concentration-dependent manner, whereas the delayed rectifier currents (IDR) remained unaffected. This IL-33-induced IA decrease was dependent on suppression of the tumorigenicity 2 (ST2) receptor and was associated with a hyperpolarizing shift in the steady-state inactivation. Antagonism of Syk abrogated the IL-33-induced IA response, while inhibition of JAK2 and PKA elicited no such effect. Exposure of DRG cells to IL-33 increased the activity of Akt, but surprisingly, neither Akt nor PI3K influenced the IL-33-induced IA response. IL-33 increased the level of phosphorylated p38 mitogen-activated protein kinase (MAPK). Chemical inhibition of p38 and genetic siRNA knockdown of p38 beta (p38), but not p38, abrogated the IA response induced by IL-33. Moreover, IL-33 increased neuronal excitability of DRG neurons and facilitated peripheral pain sensitivity in mice; both of these effects were occluded by IA blockade. Conclusions: Our present study reveals a novel mechanism by which IL-33/ST2 suppresses IA via a Syk-dependent p38 signaling pathway. This mechanism thereby increases DRG neuronal excitability and pain sensitivity in mice. Targeting IL-33/ST2-mediated p38 signaling may represent a therapeutic approach to ameliorate pain behaviors.

Topics & Concepts

Gene knockdownChemistryp38 mitogen-activated protein kinasesNociceptionProtein kinase BNeuroscienceMAPK/ERK pathwaySignal transductionReceptorCell biologyEndocrinologyInternal medicineMedicineBiologyApoptosisBiochemistryIL-33, ST2, and ILC PathwaysDermatology and Skin Diseases